Skip to main content

Posts

Showing posts from November, 2019

Desmoid Tumors Industry Size, Clinical Review, Technology and Top Players

MRFR Estimated That  “Desmoid Tumors Market Size Is Expected to Grow at a CAGR 4.5% During the Forecast Period Of 2017-2023”. Desmoid Tumors Market Overview Desmoid tumors are the benign fibrous growths which usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States. Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic desmoid tumors. On the molecular level, desmoid tumor is characterized by one of the two mutations in the gene i.e. mutations in the adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During diagnostic procedures CTNNB1 mutation is detected, especially, when pathological di

knee hyperextension or back knee Problems Causing Genu recurvatum Condition -Latest MRFR Brief

Genu recurvatum is also known as knee hyperextension or back knee. It is a type of condition that affects the knee joint to bend backward when the person is in standing position. This problem is more common in women than in men and commonly identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA).   Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial osteotomies. Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is extremely rare condition and found to be associated with other malformations such as talipes equinovarus, hip dysplasia, and absent patella.   High cost of treatment & management genu recurvatum and related disorders, and lack of infrastructure in the middle- and low-inco

global Dupuytren’s contracture market Size is expected to reach USD 5.5 billion by 2023

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle finger. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc. The  global Dupuytren’s contracture market Size is expected to reach USD 5.5 bil

Global Vasectomy Industry Brief By developments and Market Trends in 2019

The “ Global  Vasectomy Market Size  Is Expected to Reach USD 24.0 Billion at a CAGR of ~ 7.1 % During the By the End of Forecast Period 2017-2023 ”. Vasectomy is male sterilization surgery, which involves severing the male vas deferens to prevent sperm from entering into the urethra. It is a permanent procedure of preventing fertilization as reversal is costly and often does not restore the male's fertility. The advantages of minimal invasive surgical procedures such as low hospital stay, low trauma and surgical footprint, less pain has resulted in greater demand for minimal invasive procedures and thus, greater acceptance. Vasectomy Market Segmental Analysis: The global vasectomy market has been segmented on the basis of type, drug, patient, and end user. Based on the type , the market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy. Based on the drug , the market has been segmented as anesthetics, pain

Xanthoma By Type, Treatment, Clinical Review, Market Size and Growth Report

Xanthoma is a dermatology condition characterized by fatty growth underneath the skin. The growth can vary in size ranging from a pinhead to as large as a grape and usually appear like a flat bump under the skin and sometimes yellow or orange colored. They usually don’t cause any pain with some minor irritation such as tenderness and itchy feeling. There may be clusters of growths in the same area or several individual growths on different parts of the body. The exact causes of xanthoma is unknown, however, genetic factors have been indicated a cause of this conditions such as cogenosis type 1a, autosomal recessive hypercholesterolemia, alagille syndrome, and cholesterol storage disease. The global xanthoma market is expected to reach USD 8.0 billion by 2023, and the market is projected to grow at a CAGR of ~ 6.0 % during the forecast period 2017-2023. Market Competitive Some of the key players profiled in the report are AstraZeneca PLC GlaxoSmithKline PLC Johnson &a

surgery of damaged cartilage (Chondroplasty) Clinical Review and Trends

Chondroplasty is a surgery of damaged cartilage with an aim to reduce friction in joints such as knee joint. In healthy condition articular cartilage which covers the end of the bones that form the joint is smooth and provides low friction surface for the joint structures. However, in conditions such as arthritis, trauma, injuries etc. it becomes rough and damaged causing pain and swelling. Joint cartilage once damaged naturally heals poorly in most cases. Chondroplasty is performed to decrease complications, risks, and recovery time. The purpose of chondroplasty is to remove away the damaged joint surface. Key players profiled in the report are – Braun Melsungen AG NuOrtho Surgical Inc. Zimmer Biomet Holdings Inc. Smith & Nephew plc Nebula Inc. Gpcmedical Osiris Therapeutics Inc. Sklar Surgical Instruments Stryker Corporation and others. Market Segmental Analysis: The global Chondroplasty Industry has been segmented on the basis of types, anatomy, instru

Tissue Tranglutaminase Test Industry Noted CAGR of ~17.5% By 2023

The  Tissue Tranglutaminase Test Industry  is expected to grow at a CAGR of ~17.5% during the forecast period. Increasing prevalence of celiac disease drives the growth of the market. According to the World Gastroenterology Organization in 2016, 1% of the total population in western countries was diagnosed with the celiac diseases and the prevalence have substantially increased across the globe. Download Free sample copy at  https://www.marketresearchfuture.com/sample_request/824 Competitive Analysis: Some of key players profiled in the report are, Quest Diagnostics Incorporated. SQI Diagnostics Trinity Biotech ZEDIRA GmbH Demeditec Diagnostics GmbH ARUP Laboratories Cell Science Systems Bio-Rad Laboratories Inc. Pfizer Inc. Celimmune LLC. and others. Market Segmentation: The global Tissue Tranglutaminase Testing Industry has been segmented on the basis types and end users. Based on types, the market has been segmented into serological, biopsy testi

Whipple’s Disease Industry Research Overview, Market Size, Growth Analysis and Trends

Whipple’s Disease Industry Research Insights on Preventive Techniques, Diagnosis and Treatment Overview By Top Key Player Therapeutics and Strategic Assessment Report 2019 Whipple’s disease (WD) is a rare, chronic, systemic infectious bacterial disease caused by Tropheryma whipplei that affects gastrointestinal system, especially, the small intestine. The infection may spread to any part of the body but mostly it affects the central nervous system, joints, lungs, heart, and eyes. The  “global Whipple’s Disease Industry is expected to grow at the CAGR of ~3.1% during the forecast period and is estimated to reach USD 255.3 million by 2023.” Some common symptoms of this disease are weight loss, diarrhea, abdominal cramping and pain, weakness, fatigue, anemia, inflamed joints, and some other less common symptoms. The prevalence is one in one million people. The prevalence of this diseases is more in men than women. Competitive Analysis: Some of the key players in this

New Treatment and Drugs on metastases spinal tumor Market Size, Clinical review Report

The global market of metastases spinal tumor was around USD 1241.5 million in 2016 and is expected to reach USD 1547.8 million by 2023 at a projected CAGR of 3.2%. Avail a Free Sample Copy at  https://www.marketresearchfuture.com/sample_request/4084 Competitive Analysis: Some of the key players in this market are – Hoffmann-La Roche Ltd (Switzerland) Amgen Inc. (US) Novartis AG(Switzerland) Abbott (US) Beckman Coulter Inc. (US) Debiopharm Group (Switzerland) AbbVie Inc. (US) Bayer AG (Germany) and others. Segmental Analysis: The global metastases spinal tumor Industry is segmented on the basis of type, which comprise extradural, metastatic spinal tumors of the bone, and others. On the basis of diagnosis , this market is segmented into laboratory tests, imaging tests, biopsy, and others. Imaging tests includes X-Ray, Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI scan), Angiography, F-18 fluorodeoxyglucose positron emission tomography, an

Retinal Detachment Industry Reach USD 2689.2 Million at a CAGR of ~5.9% By 2023

Global Retinal Detachment Industry Is Expected to Grow at The CAGR of ~5.9% During the Forecast Period and Is Estimated to Reach USD 2689.2 Million By 2023. Global  Retinal Detachment Industry  is growing moderately and is expected to continue its growth during the forecast period. Retinal detachment is sever medical condition and medical emergency. Early diagnosis and treatment is very important to cure retinal detachment. Some of the common symptoms of retinal detachment are partial vision loss, blurred vision, suddenly seeing many floaters, and others. Retinal detachment can affect people of any age but it is more common in older adults aged from 60-70. Key Players: Some of the key players in this market are:  Carl Zeiss Meditec, Inc. (US), Centervue SpA (Italy), Co:Lab Pensacola (US), Eyenuk Inc (US), Imagine Eyes (France), HealPros, LLC (US), NEUROVISION IMAGING, LLC . (US), Optos (UK), Peek Vision Ltd. (UK), and others. Table of Contents: Chapter 1 .  Report P

infectious disease "clonorchiasis" Treatment, Symptoms, Diagnosis and Industry Outlook

Pune, India, Nov, 2017 /MRFR Press Release/- Market Research Future has a half cooked research report on the Clonorchiasis market. Market Highlights The global clonorchiasis market is expected to grow at a CAGR of 5.4% during the forecast period. Clonorchiasis is an infectious disease caused by the Chinese liver fluke Clonorchis sinensis . Clonorchiasis is dominant in Asian countries and regions, including South Korea, China, Northern Vietnam, and far-eastern Russia. China has the largest population of infected people. In the acute phase, heavier infections can cause fever, chills, epigastric pain, tender hepatomegaly, mild jaundice, and eosinophilia occur. Chronic cholangitis in heavy infections, which may progress to atrophy of liver parenchyma, portal fibrosis, and cirrhosis. Increasing prevalence of clonorchiasis, changing lifestyle, poor diet, and increasing geriatric population have driven the growth of the market. Moreover, increasing healthcare expenditure has fuelled

"Achondrogenesis" Genetic rare disease that affects cartilage and bone development?

Achondrogenesis is a genetic rare disease that affects cartilage and bone development. The condition is characterized by narrow chest, rounded abdomen, and extremely short limbs. Achondrogenesis Market includes various symptoms such as, abdominal distention, flat face, anteverted nares, frontal bossing, lethal skeletal dysplasia, hydropsfetalis, abnormal enchondral ossification, and many others. According to the U.S National Library of Medicine, the incidence of 1A and 1B, whereas achondrogenesis type 2 occur in 1 in 40,000 to 60,000 newborns. Majorly three types of achondrogenesis are known and out of these three, type 1B ( ACG1B) is most severe condition. According to an article published in GeneReviews book, it is found that SLC26A2 is the only mutated gene known to cause ACG1B. A number of factors such as, rise in facilities for patients affected by rare diseases, increasing awareness among people, increasing government assistance, and improvement in regulatory framework a

Global radiation protection apparels Market Size, Growth Analysis and Key Players Trends in 2019 To 2023

The global radiation protection apparels market is currently dominated by many market players. The major players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in May 2015, Ansell Limited acquired Microgard, a protective clothing manufacturer. With this acquisition, the company aims to increase its product portfolio and expand its geographical presence. It is estimated that the global radiation protection apparels market is expected to register a market value of USD 473 million in 2017, with a CAGR ~ 7.2% during the forecast period of 2018–2023 . Several factors such as increase in strict safety regulations by various government agencies such as Occupational Safety and Health Administration (OSHA), and National Institute for Occupational Safety and Health (NIOSH), and increase in the number of medical imaging processes are luring the growth of the market. However, high price of apparels, and detri

2019 Montelukast Intermediate Market Size, Key Companies, Technology and Trends

Montelukast Intermediate Market Overview  The Montelukast Intermediate Market is estimated to be valued at USD 4,794.763 thousand by 2023 and Expected to register CAGR of 4.34% During the Forecast Period. The Global Montelukast Intermediate Market has been evaluated as a moderately growing market, and it is expected that the market will continue to grow similarly in the near future. Factors characterizing the market growth are worldwide rising prevalence of asthma, bronchospasm, allergic rhinitis, and urticaria, burgeoning pharmaceutical industry coupled with the increasing demand from API manufacturers, and montelukast patent expiration along with the increasing presence of generics. burgeoning pharmaceutical industry coupled with the increasing demand from active pharmaceutical ingredients (APIs) manufacturers, and montelukast patent expiration along with the increasing presence of generics. All the major players are competing with each other to capture a major stake of the mar